This statistic shows the top 10 new indication approvals for existing prescription drugs in Canada in 2018. During this year, 28 new indications were approved for existing cancer drugs, which was the highest number of approvals.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Express Scripts Inc (Canada). (April 30, 2019). Leading 10 new indication approvals for existing drugs in Canada in 2018 [Graph]. In Statista. Retrieved May 30, 2025, from https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/
Express Scripts Inc (Canada). "Leading 10 new indication approvals for existing drugs in Canada in 2018." Chart. April 30, 2019. Statista. Accessed May 30, 2025. https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/
Express Scripts Inc (Canada). (2019). Leading 10 new indication approvals for existing drugs in Canada in 2018. Statista. Statista Inc.. Accessed: May 30, 2025. https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/
Express Scripts Inc (Canada). "Leading 10 New Indication Approvals for Existing Drugs in Canada in 2018." Statista, Statista Inc., 30 Apr 2019, https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/
Express Scripts Inc (Canada), Leading 10 new indication approvals for existing drugs in Canada in 2018 Statista, https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/ (last visited May 30, 2025)
Leading 10 new indication approvals for existing drugs in Canada in 2018 [Graph], Express Scripts Inc (Canada), April 30, 2019. [Online]. Available: https://www.statista.com/statistics/1082668/top-indications-for-new-indication-approvals-canada/